Health Care/Hospital

Korea's Outstanding SMEs as Frontline Fighters against COVID-19

SEOUL, South Korea, April 12, 2021 /PRNewswire/ -- BSR Korea is encouraging and supporting decent and respectful domestic SMEs of prophylaxis industry to enter the global procurement-as-a-service market, as the government-entrusted organizing agency of the COVID-19 quarantine project, Marketing S...

2021-04-12 09:00 3640

Ascletis Announced Four Clinical and Preclinical Study Abstracts of NASH and HBV Accepted as Poster Presentations by the International Liver Congress™ 2021

HANGZHOU, China and SHAOXING, China, April 12, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) announces today that four clinical and preclinical study abstracts of NASH and HBV have been accepted by the International Liver Congress™ 2021 as poster presentations. The summary of the four abs...

2021-04-12 08:30 4317

Antengene Announces First Patient Dosed in Phase II Trial of ATG-008 (Onatasertib) in Patients with Advanced Solid Tumors with Specific Genetic Alterations

SHANGHAI and HONG KONG, April 12, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-04-12 08:00 3483

IEC Telecom: Digital revolution brings new ways of serving remote areas

DUBAI, UAE, April 12, 2021 /PRNewswire/ -- The advancement of digitalisation is now bringing benefits to businesses in hard-to-reach locations, transforming the way they operate and making life easier for customers in remote areas inadequately served by terrestrial networks.

2021-04-12 04:00 3009

Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting

SUZHOU and SHANGHAI, China, April 10, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today presented updated long...

2021-04-10 21:33 6069

Hummingbird Bioscience Presents Pre-Clinical Data on its Next-Generation BCMA-TACI Dual-Specific T Cell Engager at 2021 AACR Annual Meeting

SINGAPORE, April 10, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced that the company will be presentingpre-clinical data on its BCMA-TAC...

2021-04-10 12:01 4272

Copan, putting Covid-19 challenges behind and setting up for the post-pandemic scenario

BRESCIA, Italy, April 10, 2021 /PRNewswire/ -- With an email to the main distributors, Copan group's CEO describes how the ramp-up of Covid-19-related products has been concluded, and how the company is now reorganizing to face post-pandemic challenges.

2021-04-10 01:43 5597

HealthyRecipes101.com Offers Free Access to 300 Nutritionist-approved Recipes

SAN FRANCISCO, April 9, 2021 /PRNewswire/ -- Home cooks can now access Healthy Kitchen 101 LLC's collection of nutritionist-approved recipes on its new domain atHealthyRecipes101.com , announced Luna Regina , founder of the compan...

2021-04-09 22:44 2726

RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue

Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 pneumonia based on review of unblinded safety data from the first 255 treated patients The 464-patient global Phase 2/3 COVID-19 study is ...

2021-04-09 19:00 5411

CDD Awarded $1.5M Phase 2 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization

BURLINGAME, Calif., April 9, 2021 /PRNewswire/ -- Collaborative Drug Discovery, provider ofCDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 2 SBIR grant from NIH NCATS, titled: "Intelligent Chemical Structure Browser for Drug Discovery...

2021-04-09 18:57 1999

Bionomics Successfully Completes A$22.9 million Equity Raise

ADELAIDE, Australia, April 9, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics) has completed its 1 for 6 pro rata non–renounceable entitlement offer that was announced on8 March 2021 (Entitlement Offer) and concurrent placement that was announced on17 March 2021 (Concurr...

2021-04-09 18:00 7501

Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

SHANGHAI, April 9, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-04-09 08:30 6578

Control Bionics (ASX:CBL) Partners with Numotion as Northeastern U.S. Reseller of Assistive Technology Solutions

Strategic Partnership Offers Customers More Access to Control Bionics' Industry-Leading Trilogy Product Line MILFORD, Ohio and NEW SOUTH WALES, Australia, April 9, 2021 /PRNewswire/ -- Control Bionics, a global assistive technology company specializing in speech generating devices, announced it ...

2021-04-09 04:16 1583

Seegene supports Mexico's 'back to school' campaign with COVID-19 tests and face masks

SEOUL, South Korea, April 9, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Friday it is supporting the Mexican government's push to return life to pre-pandemic days. Durin...

2021-04-09 04:08 2599

Remiges Ventures Closes Second Fund With $95 Million; Launches RDiscovery Incubator

Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Japan, announced today the final closing of its second fund, Remiges BioPharma Fund II raising a total of$95 million, and the launch of RDiscovery, a new life sciences incubator to nurture and ad...

2021-04-09 00:34 2595

Harvard Research Identifies Policy Recommendations to Support Food Donation Across Five Continents

Amid pandemic and rising rates of food insecurity, Harvard Law School Food Law and Policy Clinic and The Global FoodBanking Network address global food waste and hunger crisis. CAMBRIDGE, Mass., April 8, 2021 /PRNewswire/ -- In response to food waste, climate change, and a global hunger crisis t...

2021-04-08 22:00 2457

Shanghai Genechem Co., Ltd. (Genechem) Announces appointment of Dr. Eric Rowinsky and Dr. Manuel Hidalgo to Scientific Advisory board, and abstract presentation at AACR 2021 on Claudin 6 Ab and K-Ras TCR-T

SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr.Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr...

2021-04-08 22:00 14312

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile

* Marks vaccine's first approval in South America, following Mexico, Pakistan, China and Hungary * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effective overall in preventing severe COVID-19 diseases 14 days after vaccination TI...

2021-04-08 21:17 7587

ImmVira Announces Preclinical and Clinical Data to Be Presented at the 2021 ASCO and AACR Annual Meeting

SHENZHEN, China, April 8, 2021 /PRNewswire/ -- ImmVira today announces that the company will be presenting its first innovative product, MVR-T3011, at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting onJune 4-8 2021. Results from the first Phase 1 study of MVR-T3011 as an intr...

2021-04-08 20:47 2766

Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market

Amino acids dominate the global industry and are expected to generate revenues of$11.5 billion by 2026, says Frost & Sullivan SANTA CLARA, Calif., April 8, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the rising demand forhigh-quality meat products across the globe, especia...

2021-04-08 19:03 2229
1 ... 811812813814815816817 ... 859

Week's Top Stories